Suping Li
- Cancer Research top 1%
- MicroRNA in disease regulation 8
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery 10
- Molecular Biology top 2%
- Advanced biosensing and bioanalysis techniques 21
- RNA Interference and Gene Delivery 13
- Extracellular vesicles in disease 12
- Biomedical Engineering top 1%
- Nanoplatforms for cancer theranostics 15
- Electrochemistry top 5%
-
- Platelet Disorders and Treatments 9
-
- Inflammatory Biomarkers in Disease Prognosis 8
- Co-authors
- Guangjun NieGregory J. AndersonYanhua TianTianjiao JiJingyan WeiJian SongMotao ZhuYinlong Zhang
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Suping Li
146 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Cancer Research 1.3k
- Biomaterials 996
- Molecular Biology 3.7k
- Biomedical Engineering 2.0k
- Electrochemistry 196
Countries citing papers authored by Suping Li
This map shows the geographic impact of Suping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suping Li more than expected).
Fields of papers citing papers by Suping Li
This network shows the impact of papers produced by Suping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suping Li. The network helps show where Suping Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Suping Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 20 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 11 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 8 | |
| 13 | 2023 | 4 | |
| 14 | 2023 | 7 | |
| 15 | 2016 | 1 | |
| 16 | 2013 | 84 | |
| 17 | Study on Bark Percentage,Heartwood Percentage and Wood Density of Dalbergia odorifera | 2012 | 1 |
| 18 | The Current Situation and Existed Problems of Sunflower Mechanized Production and its Suggestion | 2011 | 1 |
| 19 | [Radioiodide treatment mediated by adenovirus transfer of human sodium iodide symporter gene into androgen-independent prostate cancer]. | 2010 | 1 |
| 20 | 2006 | 47 |
About Suping Li
Suping Li is a scholar working on Cancer Research, Hematology, Oncology, Biomaterials and Molecular Biology, having authored 162 papers that have together received 6.5k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (21 papers), Nanoplatforms for cancer theranostics (15 papers), RNA Interference and Gene Delivery (13 papers), Extracellular vesicles in disease (12 papers), Nanoparticle-Based Drug Delivery (10 papers), Platelet Disorders and Treatments (9 papers), MicroRNA in disease regulation (8 papers) and Inflammatory Biomarkers in Disease Prognosis (8 papers). The work is most often cited by research in Cancer Research (1.3k citations), Biomaterials (996 citations), Molecular Biology (3.7k citations), Biomedical Engineering (2.0k citations) and Electrochemistry (196 citations). Suping Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Guangjun Nie, Gregory J. Anderson, Yanhua Tian, Tianjiao Ji, Jingyan Wei, Jian Song, Motao Zhu, Yinlong Zhang, Guobao Xu and Jianping Lai. Their work appears in journals such as Cancer Research, Nature Communications, Nanomedicine, Nano Today and The Analyst.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.